HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells.

Abstract
β-lapachone (β-Lap), a topoisomerase inhibitor, is a naturally occurring ortho-naphthoquinone phytochemical and is involved in drug resistance mechanisms. Oxaliplatin (OxPt) is a commonly used chemotherapeutic drug for metastatic colorectal cancer, and OxPt-induced drug resistance remains to be solved to increase chances of successful therapy. To reveal the novel role of β-Lap associated with OxPt resistance, 5 μM OxPt-resistant HCT116 cells (HCT116-OxPt-R) were generated and characterized via hematoxylin staining, a CCK-8 assay and Western blot analysis. HCT116-OxPt-R cells were shown to have OxPt-specific resistance, increased aggresomes, upregulated p53 and downregulated caspase-9 and XIAP. Through signaling explorer antibody array, nucleophosmin (NPM), CD37, Nkx-2.5, SOD1, H2B, calreticulin, p38 MAPK, caspase-2, cadherin-9, MMP23B, ACOT2, Lys-acetylated proteins, COL3A1, TrkA, MPS-1, CD44, ITGA5, claudin-3, parkin and ACTG2 were identified as OxPt-R-related proteins due to a more than two-fold alteration in protein status. Gene ontology analysis suggested that TrkA, Nkx-2.5 and SOD1 were related to certain aggresomes produced in HCT116-OxPt-R cells. Moreover, β-Lap exerted more cytotoxicity and morphological changes in HCT116-OxPt-R cells than in HCT116 cells through the downregulation of p53, Lys-acetylated proteins, TrkA, p38 MAPK, SOD1, caspase-2, CD44 and NPM. Our results indicate that β-Lap could be used as an alternative drug to overcome the upregulated p53-containing OxPt-R caused by various OxPt-containing chemotherapies.
AuthorsEun Joo Jung, Hye Jung Kim, Sung Chul Shin, Gon Sup Kim, Jin-Myung Jung, Soon Chan Hong, Choong Won Kim, Won Sup Lee
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 24 Issue 12 (Jun 07 2023) ISSN: 1422-0067 [Electronic] Switzerland
PMID37373014 (Publication Type: Journal Article)
Chemical References
  • Oxaliplatin
  • Tumor Suppressor Protein p53
  • beta-lapachone
  • Superoxide Dismutase-1
  • Caspase 2
  • p38 Mitogen-Activated Protein Kinases
  • Nucleophosmin
  • Receptor Protein-Tyrosine Kinases
  • CD44 protein, human
  • Hyaluronan Receptors
  • SOD1 protein, human
Topics
  • Humans
  • Oxaliplatin (pharmacology, therapeutic use)
  • HCT116 Cells
  • Tumor Suppressor Protein p53 (metabolism)
  • Superoxide Dismutase-1 (metabolism)
  • Colorectal Neoplasms (pathology)
  • Caspase 2 (metabolism)
  • p38 Mitogen-Activated Protein Kinases (metabolism)
  • Nucleophosmin
  • Receptor Protein-Tyrosine Kinases (metabolism)
  • Apoptosis
  • Cell Line, Tumor
  • Hyaluronan Receptors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: